仲景中药材品牌怎么样 申请店铺

我要投票 仲景中药材在医疗用品行业中的票数:86 更新时间:2025-01-23
仲景中药材是哪个国家的品牌?「仲景中药材」是 仲景宛西制药股份有限公司 旗下著名品牌。该品牌发源于河南,由创始人孙锋在1998-10-15期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
仲景中药材怎么样

以“药材好,药才好”称著业界的仲景宛西制药股份有限公司,主要生产 “仲景”牌六味地黄丸、逍遥丸、天智颗粒、太子金颗粒及“月月舒”牌痛经宝颗粒为代表的中成药产品,涵盖男科、妇科、儿科及老年人用药。其中仲景牌六味地黄丸占据整个六味地黄丸约三分之一的市场份额;月月舒痛经颗粒是治疗女性痛经的知名产品,太子金颗粒被评为儿科用药的知名品牌。

多年来,公司以仲景文化和地道药材为核心,坚持“突出继承弘扬张仲景中医药文化,突出八百里伏牛山中药材资源优势,突出中药现代化、制造现代中药”的经理理念,秉承“让老中医放心,让老百姓放心,让老祖宗放心”的社会承诺和“药材好,药才好”的制药理念。在河南西峡、武陡、温县,安徽岳西、南陵,四川彭山分别建立了山茱萸、地黄、山药、牡丹皮、茯苓、泽泻六大GAP药材种植基地和初加工生产线,实现了六味地黄丸六种药材全部源于GAP基地的新突破。建立恒温、低温、常温药材仓库,采用分区、分品种、分来源、分批次的储存方式;承建河南省中药现代化工程技术研究中心,设立博士后科研工作站,拥有“现代技术集成在传统中药浓缩丸中应用”等重大科技专项支持平台,保证药材来源明明白白,消费用药安安心心。

创建张仲景大药房连锁公司、南阳张仲景医院、黑龙江漠河张仲景医院及养生院,构筑了集中药农业、中药工业、中药商业、中医医疗和中药养生为一体的健康产业链,从种植源头到终端医疗,打造并提供优质的中医药产品和服务,提高生活与生命质量,造福百姓健康。


Zhongjingwanxi Pharmaceutical Co., Ltd., known as "good medicine, good medicine" in the industry, mainly produces traditional Chinese medicine products represented by "Zhongjing" Liuwei Dihuang pill, Xiaoyao Pill, Tianzhi granule, taizijin granule and "Yueyueshu" Tongjingbao granule, covering medicine for men, women, pediatrics and the elderly. Among them, Zhongjing Liuwei Dihuang Pill accounts for about one-third of the market share of the whole Liuwei Dihuang Pill; yueyueshutongjing granule is a famous product for treating female dysmenorrhea, and taizijin granule is rated as a famous brand of pediatric medicine. Over the years, with Zhongjing culture and authentic herbs as the core, the company adheres to the management concept of "highlighting the inheritance and promotion of Zhangzhongjing traditional Chinese medicine culture, highlighting the resource advantages of 800 Li Fu Niushan traditional Chinese medicine, highlighting the modernization of traditional Chinese medicine and manufacturing modern Chinese medicine", adheres to the social commitment of "reassuring the traditional Chinese medicine, reassuring the common people, reassuring the ancestors" and the system of "good herbs, good medicine" The concept of medicine. In Xixia, Wudu and Wenxian County of Henan Province, Yuexi and Nanling of Anhui Province and Pengshan of Sichuan Province, six gap planting bases and primary processing production lines of Cornus officinalis, Rehmannia glutinosa, yam, peony bark, Poria cocos and Alisma orientalis have been established respectively, realizing a new breakthrough that all six kinds of herbs of Liuwei Dihuang Pill originate from gap base. Establish constant temperature, low temperature and normal temperature medicine warehouse, adopt the storage mode of division, variety, source and batch; undertake the construction of Henan Modern Engineering Technology Research Center of traditional Chinese medicine, set up postdoctoral scientific research workstation, and have major scientific and technological special support platforms such as "Application of modern technology integration in traditional Chinese medicine concentrated pills", so as to ensure the clear source of medicine and safe consumption of drugs Peace of mind. Establish Zhangzhongjing pharmacy chain company, Nanyang Zhangzhongjing hospital, Heilongjiang Mohe Zhangzhongjing hospital and health care hospital, build a health industry chain integrating traditional Chinese medicine agriculture, traditional Chinese medicine industry, traditional Chinese medicine business, traditional Chinese medicine medical treatment and traditional Chinese medicine health care, from planting source to terminal medical treatment, create and provide high-quality traditional Chinese medicine products and services, improve life and quality of life, benefit the people Healthy.

本文链接: https://brand.waitui.com/c0fb728ca.html 联系电话:037769669999

千城特选小程序码

7×24h 快讯

中科飞测:向特定对象发行A股股票申请获上交所受理

36氪获悉,中科飞测公告,公司于2025年1月22日收到上交所关于受理公司科创板上市公司发行证券申请的通知。上交所对公司报送的募集说明书及相关申请文件进行了核对,认为申请文件齐备,符合法定形式,决定予以受理并依法进行审核。公司本次向特定对象发行A股股票事项尚需通过上交所审核,并获得中国证监会同意注册的决定后方可实施。上述事项最终能否通过上交所审核,并获得中国证监会同意注册的决定及其时间尚存在不确定性。

48分钟前

*ST鹏博:公司股票可能被终止上市

36氪获悉,*ST鹏博公告,因中喜会计师事务所对公司出具了无法表示意见的《2023年度审计报告》,公司股票被实施退市风险警示。若公司2024年度财务会计报告被出具保留意见、无法表示意见或否定意见的审计报告以及财务报告内部控制被出具无法表示意见或者否定意见的审计报告,公司股票将被上海证券交易所决定终止上市。公司预计2024年年度归属于母公司所有者的净利润约为-7.75亿元,扣除非经常性损益后的净利润约为-7.36亿元。预计2024年年度实现营业收入约为18.87亿元。预计2024年年末归属于母公司净资产约为1.9亿元。

48分钟前

摩根大通美国国债客户多头占比创2023年以来新高

摩根大通美国国债客户调查显示,截至1月21日当周,多头占比上升2个百分点,至2023年12月4日以来的最高水平。净多头创同日以来新高,空头占比下降4个百分点,中性上升2个百分点。(界面)

48分钟前

美股大型科技股盘前多数上涨,奈飞涨超14%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,奈飞涨超14%,英伟达涨超3%,Meta、微软涨超1%,亚马逊涨0.72%,谷歌涨0.01%,特斯拉跌超1%,苹果跌0.24%。

48分钟前

热门中概股美股盘前多数下跌,理想汽车跌超2%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,理想汽车跌超2%,哔哩哔哩、腾讯音乐跌超1%,小鹏汽车跌0.93%,百度跌0.68%,阿里巴巴跌0.18%,拼多多跌0.12%,京东涨超1%,蔚来涨0.48%。

48分钟前

本页详细列出关于摩罗丹HANYAO的品牌信息,含品牌所属公司介绍,摩罗丹HANYAO所处行业的品牌地位及优势。
咨询